GLP-1 Craze Fuels Protein-Powder Maker Glanbia’s Share Rally
AI Summary
The surge in popularity of GLP-1 weight-loss medications is indirectly boosting protein supplement sales and propelling a rally in Glanbia Plc's stock. As more people turn to these drugs for weight management, the demand for protein powders is increasing as people seek to maintain muscle mass during weight loss. This trend highlights the broader intersection between pharmaceutical innovations and the health and fitness industries, showing how trends in one sector can significantly impact another.
Original Source
Read the full article at Bloomberg →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.